DarioHealth Corp Research and Development Expense Trend

DarioHealth Corp -- USA Stock  

USD 1.56  0.1  6.85%

This module enables investors to look at DarioHealth Corp various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Cost of Revenue of 2.3 M, Interest Expense of 2 M or Operating Expenses of 8.2 M, but also many exotic indicators such as Asset Turnover of 0.1247, Current Ratio of 2.11 or Free Cash Flow per Share of 0.43. This module is a perfect complement to use when analyzing DarioHealth Corp Valuation or Volatility. It can also complement various DarioHealth Corp Technical models. Additionally see analysis of DarioHealth Corp Correlation with competitors.
Showing smoothed Research and Development Expense of DarioHealth Corp with missing and latest data points interpolated. A component of Operating Expenses representing the aggregate costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service.
Research and Development Expense  10 Years Trend  
Increasing
Slightly volatile
 Research and Development Expense 
      Timeline 

DarioHealth Corp Research and Development Expense Over Time

2015-12-31  2,565,000 
2016-12-31  2,565,000 
2017-12-31  3,425,263 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  2,326,593
Geometric Mean  2,103,437
Coefficient Of Variation  50.83
Mean Deviation  962,883
Median  1,501,265
Standard Deviation  1,182,679
Range  3,410,735
R Value  0.65
R Squared  0.42
Significance  0.023179
Slope  211,974

Currently Trending

MSFT   
 NMS 
Purchased over 30 shares of
1 hour ago ago
Traded for 85.35
CRM   
 NYQ 
Purchased over 20 shares of
1 hour ago ago
Traded for 103.94
S   
 NYQ 
Purchased over 500 shares of
1 hour ago ago
Traded for 5.69